ME, D., TG, M., K, A., SK, E., J, P., NM, K., . . . HM, C. (2017). Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy. Toxicologic pathology, 45(2), 344. https://doi.org/10.1177/0192623316634231
Chicago Style (17th ed.) CitationME, Dunn, et al. "Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction Between Physiologic and Pathologic Left Ventricular Hypertrophy." Toxicologic Pathology 45, no. 2 (2017): 344. https://doi.org/10.1177/0192623316634231.
MLA (9th ed.) CitationME, Dunn, et al. "Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction Between Physiologic and Pathologic Left Ventricular Hypertrophy." Toxicologic Pathology, vol. 45, no. 2, 2017, p. 344, https://doi.org/10.1177/0192623316634231.